Status:
COMPLETED
Transit Bipartition After Sleeve Gastrectomy
Lead Sponsor:
Ruhr University of Bochum
Conditions:
Obesity, Morbid
Weight Gain
Eligibility:
All Genders
18+ years
Brief Summary
Retrospective analysis of 100 morbidly obese patients who underwent a transit bipartition (TB) procedure ("Single Anastomosis Sleeve Ileal bypass") for inadequate weight loss or weight recidivism afte...
Detailed Description
Prospective data base of 100 consecutive morbidly obese patients who had undergone transit bipartition (TB, also termed "Single Anastomosis Sleeve Ileal bypass") after a previous sleeve gastrectomy (L...
Eligibility Criteria
Inclusion
- TB for excess weight loss (EWL) \< 50% ≥ 12 months post LSG or weight recidivism of \> 5 kg/qm with a body mass index (BMI) \> 30 kg/qm.
Exclusion
- endocrine disorders other than T2DM, major psychiatric disorders, ASA ≥ III, pregnancy.
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 20 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04782648
Start Date
November 1 2017
End Date
December 20 2020
Last Update
March 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum Vest GmbH
Recklinghausen, North Rhine-Westphalia, Germany, 45657